May 10, 2017 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:IMPL) (OTCQX:IMPZY) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, announces that, on May 5, 2017, the Company’s Shareholders’ Meeting, in accordance with the provisions of article L.421-14 V of the Monetary and […]